The U.S. Securities and Trade Commission on Thursday submitted insider trading rates from the main information and facts officer of a pharmaceutical enterprise in an alleged $8 million plan, whilst the U.S. Justice Division filed legal costs in the situation. The SEC stated in its lawsuit that among September 2017 […]